S-1GTBPCIK 0000109657

GT Biopharma, Inc.

Name: SEC EDGAR filing 0001493152-26-046618
Creator: GT Biopharma, Inc.
License: https://www.usa.gov/government-works

IPO registration (S-1) filed October 9, 2026.

Registration statement filed by a company planning to issue securities to the public for the first time.

Open the filing on SEC.gov

New to the S-1? What it is and how to read one

Filing facts

Accession number: 0001493152-26-046618
Filer: GT Biopharma, Inc.
Ticker: GTBP
CIK: 0000109657
Form type: S-1
Form description: IPO registration
Filed at: October 9, 2026
Industry: SIC 2834Pharmaceutical Preparations
Last verified: October 10, 2026SecFilingDex pulls from EDGAR with daily cadence

More filings from GT Biopharma, Inc.

See all 45 filings from GT Biopharma, Inc. →

Provenance

Authoritative source — SEC EDGAR

https://www.sec.gov/Archives/edgar/data/109657/000149315226046618/0001493152-26-046618-index.htm ↗

Filer's full EDGAR submission history

EDGAR · GT Biopharma, Inc. (0000109657) ↗

Machine-readable JSON twin (LLM-citation friendly)

/api/filing/0001493152-26-046618.json

SecFilingDex republishes SEC EDGAR data with provenance. EDGAR is the authoritative source. SecFilingDex is independent and not affiliated with the U.S. Securities and Exchange Commission. Nothing on this page constitutes investment, legal, tax, or other professional advice.